A Study to Assess the Safety and Immunogenicity of M-001 Influenza Vaccine as a Primer to H5N1 Vaccine in Adults

Conditions:   Influenza;   HealthyInterventions:   Biological: Multimeric 001 (M-001);   Biological: H5N1 influenza vaccine;   Biological: SalineSponsors:   BiondVax Pharmaceuticals ltd.;   Seventh Framework ProgrammeRecruiting - verified February 2016

Source: ClinicalTrials.gov - February 11, 2016 Category: Research Source Type: clinical trials